FBTFirst Trust NYSE Arca Biote...


$ 153.57 $ -0.83 (-0.54 %)    

Monday, 01-Jul-2024 14:42:45 EDT
QQQ $ 486.52 $ 5.06 (1.05 %)
DIA $ 393.25 $ 1.83 (0.47 %)
SPY $ 548.30 $ 3.67 (0.67 %)
TLT $ 90.61 $ 0.70 (0.78 %)
GLD $ 215.57 $ -0.01 (0 %)
$ 152.7064
$ 153.57
$ 0.00 x 0
$ 153.40 x 524
$ 153.57 - $ 153.57
$ 130.27 - $ 161.41
13,230
na
na
$ 0.75
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 mifepristone-abortion-pill-access-in-limbo-justice-department-may-ask-supreme-courts-intervention

U.S. Attorney General Merrick Garland said that the Justice Department would file an appeal with the U.S. Supreme Court seeki...

 womens-reproductive-rights-us-court-preserves-access-to-abortion-pill-for-now-but-with-tighter-rules

A U.S. federal appeals court has temporarily blocked a decision by a Texas judge to halt the FDA's approval of a widely u...

 new-york-and-california-prepare-for-potential-mifepristone-ban-in-texas-with-stockpiling-of-alternative-abortion-medications

New York and California are stockpiling an alternative abortion medication in case a Texas judge's order suspending the F...

 attorney-generals-of-over-20-states-sound-alarm-over-suspension-of-abortion-med-approval-devastating-risks-ahead

In a new court filing, the Democratic attorneys general for 23 U.S. states have reportedly warned that a federal judge's ...

 us-judge-weighs-nationwide-ban-on-abortion-pills

U.S. District Judge Matthew Kacsmaryk questioned President Joe Biden's administration lawyers on whether the federal regu...

 q2-growth-nothing-short-of-virtuous-economist

The coronavirus pandemic that began in 2020 and is persisting today has led many investors to hold poor market expectations. Bu...

 5-top-etfs-with-exposure-to-biogen

For the first time in 18 years, there was a new treatment for Alzheimer’s Disease approved by the FDA.

 3-etfs-for-astrazenecas-39b-alexion-pharmaceuticals-takeover

The biotechnology space is always fertile territory for mergers and acquisitions, and that theme was on display over the weeken...

 election-history-says-buy-biotech-dip

Biotechnology exchange-traded funds were hot until they weren't. History indicates recent weakness in the previously high-f...

 post-pandemic-stars-could-align-for-this-biotech-etf

These days, it's not hard to find winners among health care exchange-traded funds and that's true of both established a...